Guangdong Biolight Meditech Co Ltd (300246) - Total Assets

Latest as of June 2026: CN¥2.45 Billion CNY ≈ $359.07 Million USD

Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) holds total assets worth CN¥2.45 Billion CNY (≈ $359.07 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Guangdong Biolight Meditech Co Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Guangdong Biolight Meditech Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Guangdong Biolight Meditech Co Ltd (300246) market capitalisation for the company's overall valuation and market capitalisation.

Guangdong Biolight Meditech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Guangdong Biolight Meditech Co Ltd's total assets of CN¥2.45 Billion consist of 50.6% current assets and 49.4% non-current assets. Review Guangdong Biolight Meditech Co Ltd total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	26.8%
Accounts Receivable	CN¥242.14 Million	9.6%
Inventory	CN¥287.82 Million	11.4%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥116.51 Million	4.6%
Goodwill	CN¥15.49 Million	0.6%

Asset Composition Trend (2008–2025)

This chart illustrates how Guangdong Biolight Meditech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 300246 stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangdong Biolight Meditech Co Ltd's current assets represent 50.6% of total assets in 2025, a decrease from 78.9% in 2008.
Cash Position: Cash and equivalents constituted 26.8% of total assets in 2025, up from 18.3% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2008.
Asset Diversification: The largest asset category is inventory at 11.4% of total assets.

Guangdong Biolight Meditech Co Ltd Competitors by Total Assets

Key competitors of Guangdong Biolight Meditech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Cochlear Ltd AU:COH	Australia	AU$2.83 Billion
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	China	CN¥16.89 Billion
Jafron Biomedical Co Ltd SHE:300529	China	CN¥5.20 Billion
Stratec SE XETRA:SBS	Germany	€408.98 Million
Shinhung KO:004080	Korea	₩153.50 Billion
DRTECH Corporation KQ:214680	Korea	₩235.84 Billion
Novacyt PA:ALNOV	France	€40.28 Million
Diagnostic Medical Systems SA PA:ALDMS	France	€62.52 Million

Guangdong Biolight Meditech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.44	2.19	1.84
Quick Ratio	1.09	1.72	1.44
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥376.42 Million	CN¥642.30 Million	CN¥385.96 Million

Guangdong Biolight Meditech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong Biolight Meditech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.52
Latest Market Cap to Assets Ratio	0.24
Asset Growth Rate (YoY)	0.9%
Total Assets	CN¥2.52 Billion
Market Capitalization	$609.04 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong Biolight Meditech Co Ltd's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Guangdong Biolight Meditech Co Ltd's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Guangdong Biolight Meditech Co Ltd (2008–2025)

The table below shows the annual total assets of Guangdong Biolight Meditech Co Ltd from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.52 Billion ≈ $369.09 Million	+0.94%
2024-12-31	CN¥2.50 Billion ≈ $365.66 Million	-1.40%
2023-12-31	CN¥2.53 Billion ≈ $370.86 Million	+3.92%
2022-12-31	CN¥2.44 Billion ≈ $356.88 Million	+41.83%
2021-12-31	CN¥1.72 Billion ≈ $251.62 Million	+6.99%
2020-12-31	CN¥1.61 Billion ≈ $235.18 Million	+67.16%
2019-12-31	CN¥961.46 Million ≈ $140.69 Million	+4.72%
2018-12-31	CN¥918.15 Million ≈ $134.35 Million	+14.74%
2017-12-31	CN¥800.22 Million ≈ $117.10 Million	+16.55%
2016-12-31	CN¥686.57 Million ≈ $100.47 Million	+18.24%
2015-12-31	CN¥580.65 Million ≈ $84.97 Million	+11.88%
2014-12-31	CN¥519.01 Million ≈ $75.95 Million	+10.03%
2013-12-31	CN¥471.72 Million ≈ $69.03 Million	+8.82%
2012-12-31	CN¥433.50 Million ≈ $63.43 Million	+9.34%
2011-12-31	CN¥396.48 Million ≈ $58.02 Million	+209.73%
2010-12-31	CN¥128.01 Million ≈ $18.73 Million	+23.82%
2009-12-31	CN¥103.38 Million ≈ $15.13 Million	+31.86%
2008-12-31	CN¥78.41 Million ≈ $11.47 Million	--

About Guangdong Biolight Meditech Co Ltd

SHE:300246 China Medical Devices

Market Cap

$609.04 Million

CN¥4.16 Billion CNY

Market Cap Rank

#11337 Global

#3184 in China

Share Price

CN¥15.72

Change (1 day)

+4.73%

52-Week Range

CN¥7.83 - CN¥21.57

All Time High

CN¥30.12